share_log

PM360 Announces Winners of The 10th Annual ELITE 100 Awards

PM360 Announces Winners of The 10th Annual ELITE 100 Awards

PM360 宣佈第十屆年度 ELITE 100 大獎的獲獎者
PR Newswire ·  05/23 22:00

The Most Influential People and Teams in Healthcare and the Life Sciences

醫療保健和生命科學領域最具影響力的人物和團隊

NEW YORK, May 23, 2024 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 10th Annual ELITE 100. The ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people and teams in the healthcare and life sciences industries based on their career accomplishments. Out of about 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry.

紐約,2024 年 5 月 23 日 /PRNewswire/-- PM360是製藥、生物技術、診斷和醫療器械領域營銷決策者的首要信息資源,今天宣佈了其10位獲獎者第四 年度精英100強。精英 (E非同尋常的 • L讀者 • 創新者 • T變形金剛 • E根據他們的職業成就,intrepreneurs)代表了醫療保健和生命科學行業中最具影響力的人和團隊。在大約 500 份參賽作品中,有 100 名獲獎者由 PM360 不同類別的編輯人員,涵蓋該行業的方方面面。

Nominees for the award are evaluated based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. Ultimately, the ELITE 100 represent a group of individuals and marketing teams who have made a significant impact on the healthcare industry throughout their careers or show great promise as future leaders based on what they have achieved so far.

對該獎項的提名者進行評估的依據是他們的成就;他們的老闆、客戶和同事的證詞;以及反映其努力影響的支持證據。歸根結底,ELITE 100代表着一群個人和營銷團隊,他們在整個職業生涯中對醫療保健行業產生了重大影響,或者根據迄今爲止取得的成就顯示出作爲未來領導者的巨大希望。

"The life sciences and healthcare industries are constantly changing and we need professionals like this year's ELITE 100," says Anna Stashower, CEO and Publisher of PM360. "These individuals and teams are starting new businesses that fill needs in our industry, incorporating sustainability into the massive pharmaceutical and life sciences space, leveraging data and tech to get medicines to niche patient groups. And not only are these winners dedicating their work to better patient experiences and outcomes, they're influencing the next generation of industry ELITEs. They are instilling the confidence in others to grow as professionals and compassionate coworkers, pushing the boundaries of what's always been done to make better systems, products, services, and more for their clients and the patients they serve."

《生命科學和醫療保健行業在不斷變化,我們需要像今年的ELITE 100這樣的專業人士,” 首席執行官兼出版商安娜·斯塔斯豪爾說 PM360。“這些個人和團隊正在創辦新業務,以滿足我們行業的需求,將可持續發展納入龐大的製藥和生命科學領域,利用數據和技術爲利基患者群體提供藥物。而且,這些獲獎者不僅致力於改善患者體驗和療效,還影響着下一代行業精英。他們正在向他人灌輸信心,讓他們成長爲專業人士和富有同情心的同事,突破了爲客戶和所服務的患者提供更好的系統、產品、服務等方面所做工作的界限。”

PM360 also selects one person as the "Uber ELITE," or the individual among the nominees who best personifies the criteria of a PM360 ELITE. This year that honor goes to Adele Gulfo, CEO, Biopharma Commercial Unit of Sumitomo Pharma. Adele started out her career on the commercial side of pharmaceuticals at Pfizer, where she was instrumental in the development, launch and commercial success of LIPITOR, which became the world's best-selling medicine. As US Country Manager, she led Commercial Operations and Market Access across all Biopharma businesses, including

PM360 還會選擇一個人作爲 “Uber ELITE”,或被提名者中最能體現以下標準的個人 PM360 精英。今年,該榮譽歸於住友製藥生物製藥商業部首席執行官阿黛爾·古爾福。阿黛爾在輝瑞的藥品商業方面開始了她的職業生涯,在那裏她對LIPITOR的開發、推出和商業成功發揮了重要作用,LIPITOR已成爲世界上最暢銷的藥物。作爲美國區域經理,她領導了所有生物製藥業務的商業運營和市場準入,包括

Specialty and Oncology. She also ran Pfizer's Latin America business (+$4B) across 23 countries.

專科和腫瘤學。她還經營輝瑞在23個國家的拉丁美洲業務(+40億美元)。

Adele also held Vice President roles within AstraZeneca, including leading business development/innovation and design for launch brands as well as the multi-billion-dollar Cardiovascular business unit. She oversaw the launch of Crestor, which generated close to $60B over its patented life.

阿黛爾還曾在阿斯利康擔任副總裁一職,包括領導旗下品牌的業務開發/創新和設計,以及價值數十億美元的心血管業務部門。她監督了Crestor的推出,Crestor在其專利壽命內創造了近600億美元的收入。

From 2018 to 2019, Adele served as Chief Commercial Development Officer at Roivant Sciences, where she was influential in the formation of Sumitovant and in preparations for the launches of ORGOVYX (Prostate Cancer) and MYFEMBREE (Women's Health). Now, as as Chief Executive Officer, Biopharma Commercial Unit at Sumitomo Pharma America since the Company's formation in 2023, she provides oversight of the Company's commercial products APTIOM, GEMTESA, LATUDA, MYFEMBREE, ORGOVYX, and RETHYMIC.

從2018年到2019年,阿黛爾在Roivant Sciences擔任首席商業開發官,在Sumitovant的成立以及ORGOVYX(前列腺癌)和MYFEMBREE(女性健康)的推出做準備方面,她發揮了影響力。現在,自住友製藥美國公司於2023年成立以來,她一直擔任該公司生物製藥商業部門的首席執行官,負責監督該公司的商業產品APTIOM、GEMTESA、LATUDA、MYFEMBREE、ORGOVYX和RETHYMIC。

Adele Gulfo will serve as the keynote speaker at the annual ELITE 100 Awards Event to celebrate this year's winners. The event will be held at 230 FIFTH in New York City on June 18th starting at 7 PM EST. Tickets for the event can be purchased at .

阿黛爾·古爾福將在一年一度的精英100強頒獎典禮上擔任主旨發言人,該活動旨在表彰今年的獲獎者。該活動將於6月18日在紐約市第五區230號舉行第四 從美國東部標準時間晚上7點開始。活動門票可以在以下網址購買 。

All of the 100 winners were profiled in PM360's May 2024 issue. You can read their profiles online at

對所有 100 名獲獎者進行了簡介 PM360是 2024 年 5 月號。你可以在線閱讀他們的個人資料

About PM360

關於 PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

PM360 是製藥、生物技術、診斷和醫療器械行業的營銷決策者必讀的首要雜誌。每月出版, PM360 是唯一一本專注於提供產品經理和藥品營銷專業人員在複雜且高度監管的醫療環境中取得成功所需的全方位實用信息的期刊。

The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the "360" in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

該期刊有針對性且富有洞察力的社論側重於直接影響關鍵決策的問題,包括:前沿戰略的規劃和實施、趨勢、最新技術進步、品牌/營銷、廣告/促銷、患者/專業教育、銷售、市場研究、公關和領導力。此外,標題中的 “360” 表示了這份重要的操作性信息以及個人和職業見解的跨度,讀起來既愉快又發人深省。

By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

通過提供完整的豐富內容, PM360 對於忙碌而富有成效的營銷專業人員來說,確實是保持行業領先地位的必不可少的工具。

Contact:
Kayla Walsh
Senior Editor
PM360
646-300-8114

聯繫人:
凱拉·沃爾什
高級編輯
PM360
646-300-8114

SOURCE PM360

來源 PM360

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論